175 related articles for article (PubMed ID: 38042449)
1. Radiation Therapy in Alzheimer's Disease: A Systematic Review.
Kaul D; Ehret F; Roohani S; Jendrach M; Buthut M; Acker G; Anwar M; Zips D; Heppner F; Prüss H
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):23-41. PubMed ID: 38042449
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial.
Kim DY; Kim JS; Seo YS; Park WY; Kim BH; Hong EH; Kim JY; Cho SJ; Rhee HY; Kim A; Kim KY; Oh DJ; Chung WK
J Alzheimers Dis; 2023; 95(3):1263-1272. PubMed ID: 37638435
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Neuroinflammation by Low-Dose Radiation Therapy in an Animal Model of Alzheimer's Disease.
Yang EJ; Kim H; Choi Y; Kim HJ; Kim JH; Yoon J; Seo YS; Kim HS
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):658-670. PubMed ID: 34144146
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease.
Casali BT; Reed-Geaghan EG; Landreth GE
J Neuroinflammation; 2018 Feb; 15(1):43. PubMed ID: 29448961
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
Maiti P; Paladugu L; Dunbar GL
BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation as a Potential Therapeutic Target in Alzheimer's Disease.
Liu P; Wang Y; Sun Y; Peng G
Clin Interv Aging; 2022; 17():665-674. PubMed ID: 35520949
[TBL] [Abstract][Full Text] [Related]
7. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer's disease.
Kaur D; Behl T; Sehgal A; Singh S; Sharma N; Badavath VN; Ul Hassan SS; Hasan MM; Bhatia S; Al-Harassi A; Khan H; Bungau S
Metab Brain Dis; 2022 Jan; 37(1):1-16. PubMed ID: 34436747
[TBL] [Abstract][Full Text] [Related]
9. Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review.
Ismail M; Alsalahi A; Imam MU; Ooi J; Khaza'ai H; Aljaberi MA; Shamsudin MN; Idrus Z
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085610
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
Kaur D; Behl T; Sehgal A; Singh S; Sharma N; Bungau S
Neurochem Res; 2021 Nov; 46(11):2832-2851. PubMed ID: 34357520
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
[TBL] [Abstract][Full Text] [Related]
12. Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease.
Ceyzériat K; Zilli T; Millet P; Frisoni GB; Garibotto V; Tournier BB
Curr Alzheimer Res; 2020; 17(2):112-125. PubMed ID: 32129164
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic insight into the role of metformin in Alzheimer's disease.
Sanati M; Aminyavari S; Afshari AR; Sahebkar A
Life Sci; 2022 Feb; 291():120299. PubMed ID: 34999113
[TBL] [Abstract][Full Text] [Related]
14. Experimental models of Alzheimer's disease for deciphering the pathogenesis and therapeutic screening (Review).
Li X; Bao X; Wang R
Int J Mol Med; 2016 Feb; 37(2):271-83. PubMed ID: 26676932
[TBL] [Abstract][Full Text] [Related]
15. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer's Disease: A Systematic Review of Preclinical Studies.
Hosseini L; Mahmoudi J; Pashazadeh F; Salehi-Pourmehr H; Sadigh-Eteghad S
J Mol Neurosci; 2021 Jul; 71(7):1425-1435. PubMed ID: 33907963
[TBL] [Abstract][Full Text] [Related]
17. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
18. Emerging drug targets for Aβ and tau in Alzheimer's disease: a systematic review.
West S; Bhugra P
Br J Clin Pharmacol; 2015 Aug; 80(2):221-34. PubMed ID: 25753046
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
20. Neuropathology of Alzheimer's Disease.
Trejo-Lopez JA; Yachnis AT; Prokop S
Neurotherapeutics; 2022 Jan; 19(1):173-185. PubMed ID: 34729690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
